Introduction
Superfi cial fungal infections are the most common fungal infections. According to World Health Organization (WHO), the prevalence rate of superfi cial mycotic infection worldwide has been found to be 20-25%. [1] Its prevalence varies in different countries. [2, 3] It is more prevalent in tropical and subtropical countries like India where the heat and humidity is high for most part of the year. [4] Dermatophytosis is the most important group of superfi cial fungal infections caused by dermatophytes, which is a group of fungi that are capable of growing by invading the keratin of skin, hair, and nail for obtaining nutrients. There are several reports on intracontinental variability of the global incidence because of the change in climatic condition across the world. [3] Over the past decades, non-dermatophytes, as agents of superfi cial fungal infection in humans, produce lesions that are clinically similar to those caused processed as per standard mycological techniques. Samples were collected from the same site for 3 consecutive days and processed to rule out contaminants. These clinical samples (infected skin, nails, and hair) were collected in small black papers for easy visualization and absorption of moisture. Samples were also sent for histopathological study, whenever necessary, to rule out contamination. A detailed history of the selected patients was taken regarding duration of illness, involvement of other sites, and history of similar episodes in the family members and immunocompromised condition were collected along with the demographic details. The 297 samples were subjected to direct microscopy in 10% potassium hydroxide (KOH) for skin samples and 40% KOH for nail samples. The samples were cultured in Sabourauds dextrose agar tubes into two sets, one group with chloramphenicol and other with cycloheximide (to prevent growth with saprophytic fungi and bacteria); and incubated at 37 and 25°C; respectively. The cultures were examined for presence of growth, colony morphology, and pigment production. Slide cultures were prepared for identifi cation of specifi c fungal species.
Results
A total of 15,950 patients were screened during the study period of 1 year, of which only 297 were clinically diagnosed to have superfi cial fungal infection. Clinically, tinea corporis 78% (215/297) was the commonest superfi cial fungal infection, followed by tinea cruris 10% (28/297), tinea manuum 2.5% (7/297), tinea faciei 1.8% (5/297), tinea pedis 0.7% (2/297), onychomycosis 6.7% (20/297), and piedra 0.6% (2/297) [ Table 1 ].
Among the 297 patients, 167 (56%) were male and 130 (44%) were female. The predominant age group affected was 22-45 years. Of the 297 suspected cases of superfi cial fungal infections, 160 (50.5%) were confi rmed by KOH microscopic examination, 82 were both KOH and culture positive, and 55 were negative to both microscopy and culture. Thus, the prevalence of fungal infection was 27.6%.
On the basis of culture characteristics, out of 82 culture positive samples, 62 (75.6%) grew dermatophytes and 20 (24.4%) grew non-dermatophytes. Among the isolated dermatophytes, Trichophyton rubrum was the commonest (79%), followed by T. mentagrophytes (14.5%), Microsporum canis (3.2%), and M. gypseum (3.2%) [ Table 1 ]. Among the isolated non-dermatophytes, Candida was the commonest species (60%). Clinically, all non-dermatophytic infections affected the nails (onychomycosis) [ Table 2 ].
Discussion
A total of 297 cases were clinically diagnosed to have superfi cial fungal infection, which is common in those aged 30-45 years, as this is the age of maximum outdoor activity. In this study, the prevalence of dermatomycoses was 27.6%. Skin is the commonest site of superfi cial infection, followed by nail and hair. Tinea corporis (78.1%) was the commonest clinical presentation, followed by tinea cruris (10.1%), tinea manuum (2.5%), tinea faciei (1.8%), and tinea pedis (0.7%). Similar fi ndings were observed in the study by Mishra et al., [6] and Goldstein et al. [7] This study showed an increase in the number of non-dermatophytes, which are now being widely reported. As reported in a study conducted by Patel et al., [8] dermatophytes commonly isolated were T. rubrum, followed by T mentagrophytes, M. canis, and M. gypseum; this is similar to the study conducted by Patel et al., [8] in Gujarat. Epidermophyton fl occosum (31.4%) was the commonest dermatophyte isolated in Iran [9] and also noted in the fi ndings of the study by Muhsin et al., in Iraq. [10] M. canis was commonly isolated in the study conducted by Fortuño et al., in Spain [11] and in the study conducted by Mangiaterra et al., in Argentina. [12] T. tonsurans was commonly isolated in the United States which was observed by Weitzman et al. [13] T. mentagrophytes was common among dermatophytes in Poland as reported by Nowicki [14] and in Jordan by Abu-Elteen et al. [15] The distribution of the dermatophytosis and their etiological agents varies with geographical location, the trends of people living in communities, and the socioeconomic conditions. In our study, the percentage of non-dermatophytic fungus isolated was 24.4%. The commonest non-dermatophyte isolated was Candida, followed by Aspergillus, Alternaria, Curvularia, and Fusarium. In a study by Grover et al., [16] the percentage of non-dermatophytes was 34%. Non-dermatophytes are being increasingly reported to cause infection of nail .
Tenia corporis is the commonest clinical presentation of superfi cial fungal infection. Dermatophytes is the commonest isolate causing superfi cial fungal infection, and in that T. rubrum is the commonest species. Besides dermatophytes, non-dermatophytic fungi are also emerging as important cause of superfi cial mycosis, where candidiasis is the commonest species of non-dermatophytes affecting nails.
Because therapeutic options are different for different fungal species and intrinsic resistance is common among Candida species, identifi cation of species is vital to curtail the drug resistance among the fungus.
Direct microscopy, along with culture, needs to be included in the fungal infections identifi ed clinically, especially where molecular diagnostics are not available.
